Date: August 7th, 2025 11:23 AM Author: nighttime stirring legend
In recent months, major drug companies have been pouring money into domestic manufacturing in response to tariff threats.
AstraZeneca is going to spend $50 billion to expand its drug manufacturing in the U.S. Johnson & Johnson said it is investing $55 billion into U.S.-based research and development, while Eli Lilly said it will spend $27 billion to build four new manufacturing plants in the U.S.